Paper511355
Trimethoprim/sulphonamide: concluding remarks.
Marget W. Infection, 1979. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Trimethoprim/sulphonamide: concluding remarks. Papers, record 511355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/511355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sulfonamides | Major topic |
| Trimethoprim | Major topic |
| Urinary Tract Infections | Major topic |
| Aged | |
| Animals | |
| Child | |
| Drug Administration Schedule | |
| Drug Combinations | |
| Humans | |
| Sulfadiazine | |
| Sulfamethoxazole |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 389810 | The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues. | Infection | 1979 | https://conductscience.org/library/papers/389810 | PubMed |
| 2 | 389811 | Efficacy of two trimethoprim-sulphonamide combinations in experimental pyelonephritis in the rat. | Infection | 1979 | https://conductscience.org/library/papers/389811 | PubMed |
| 3 | 389808 | The effect of trimethoprim-sulphonamide, trimethoprim and sulphonamide on the occurrence of resistant enterobacteriaceae in human intestinal flora. | Infection | 1979 | https://conductscience.org/library/papers/389808 | PubMed |
| 4 | 389814 | A clinical study of co-trimazine in comparison with co-trimoxazole and sulphalene in urinary tract infections. | Infection | 1979 | https://conductscience.org/library/papers/389814 | PubMed |
| 5 | 389812 | Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim. | Infection | 1979 | https://conductscience.org/library/papers/389812 | PubMed |
| 6 | 389816 | Clinical studies on co-trimazine in children. | Infection | 1979 | https://conductscience.org/library/papers/389816 | PubMed |
| 7 | 511351 | Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim. | Infection | 1979 | https://conductscience.org/library/papers/511351 | PubMed |
| 8 | 389813 | Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections. | Infection | 1979 | https://conductscience.org/library/papers/389813 | PubMed |
| 9 | 511354 | Comparison of long- and short-term treatment of recurrent urinary tract infection. | Infection | 1979 | https://conductscience.org/library/papers/511354 | PubMed |
| 10 | 389809 | Synergistic activity of co-trimazine and co-trimoxazole in the urine. | Infection | 1979 | https://conductscience.org/library/papers/389809 | PubMed |
| 11 | 511349 | Studies on the optimal dosage of co-trimazine in children. | Infection | 1979 | https://conductscience.org/library/papers/511349 | PubMed |
| 12 | 511353 | General survey of trimethoprim combinations in the treatment of urinary tract infections. | Infection | 1979 | https://conductscience.org/library/papers/511353 | PubMed |
| 13 | 389818 | Treatment of urinary tract infections with sulphonamide and/or trimethoprim. A preliminary report from a multipractice study. | Infection | 1979 | https://conductscience.org/library/papers/389818 | PubMed |
| 14 | 389807 | Synergistic antibacterial activity in vitro of trimethoprim and sulphonamides and the importance of pharmacokinetic properties for optimal therapy. | Infection | 1979 | https://conductscience.org/library/papers/389807 | PubMed |
| 15 | 511352 | Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function. | Infection | 1979 | https://conductscience.org/library/papers/511352 | PubMed |
| 16 | 511347 | Co-trimazine distribution in the canine prostate. | Infection | 1979 | https://conductscience.org/library/papers/511347 | PubMed |
| 17 | 511350 | Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 2: Comparative pharmacokinetics of five sulphonamides. | Infection | 1979 | https://conductscience.org/library/papers/511350 | PubMed |
| 18 | 389817 | Clinical study of co-trimazine in urinary tract infections: a comparison with nitrofurantoin. | Infection | 1979 | https://conductscience.org/library/papers/389817 | PubMed |
| 19 | 511348 | Renal lymph and interstitial fluid concentration of co-trimazine: an experimental study in dogs. | Infection | 1979 | https://conductscience.org/library/papers/511348 | PubMed |
| 20 | 389815 | The use of co-trimazine and co-trimoxazole in elderly patients with urinary tract infections. | Infection | 1979 | https://conductscience.org/library/papers/389815 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/511355
GET https://conductscience.org/api/papers/v1/511355/authors